Hereditary Breast and Ovarian Cancer Syndrome Flashcards
BRCA 1 associated with what % of epithelial ovarian and breast cancers
15%
BRCA 2 associated with what % of epithelial ovarian and breast cancers
5%
BRCA genes are associated with what fuck up
tumor suppression genes, so when they are messed up, or when a defect allele is inherited, risk of cancer increases
risk of breast cancer if BRCA 1/2 positive by age 70 is
70%
and 10 year risk is approximately 10%
ovarian cancer risk of someone with BRCA 1 vs 2 is
BRCA 1 : 40%
BRCA 2 : 20%
BRCA + also increases your risk for getting these other cancers
pancreatic, prostate, uterine, melanoma
Pts should get genetic counseling if
- personal or family history (1st or 2nd degree relative) of breast or ovarian cancer
- high risk groups (ashkenazi jews, French Canadians, incelanders
Genetic counseling should address:
1) detailed pedigree and risk assessment
2) informed consent should include a discussion on the ethical issues of disclosure/non-disclosured
3) Pre and post test cousneling
4) cost of testing (and degree of insurance coverage an idfentified risk can cause)
Those with the following should get further genetic counseling
- personal history of ovarian cacner
- breast cancer before 45 yo
- breast cancer any cage, and being Ashkenazi Jew
- positive family history (with increasing numbers and increasing degrees of closeness)
Different types of BRCA testing include:
1) single site testing (relatives of an individual whose specific genetic error is known
2) targeted multisite testing (members of high risk groups where a specific allelic error is unknown
3) BRCA rearrangement testing (look at entire BRCA gene, more expensive
Treatment options for BRCA 1 or 2 postiive
1) Screen ages 25-29 with 6-12 monthly clinical breast exam and MRI
2) after age 30, alternate mammagram and MRI every 6 months, in addition to clinical breast exam
risk reducing BSO
- most effective management option is BSO
- recommended 35-40yo for BRCA 1
- recommended 40-45 for BRCA 2
- routine CA125 and US screening is only okay 30-35 as an interim measure because it will have too high false positive
- BS is not recommended for high risk women (though okay in lower risk women, and should have BO as soon as possible.
risk reducing bilateral mastectomy
- risk of nipple sparing unknown currently
risk reducing medications
- OCPs
- tamoxifen (reduce breast cancer risk in BRCA 2, but not BRCA 1
- estrogen for those with BSO reduces the negative effects of BSO (bones, cardiovascular) but does not reduce the effectiveness
Fertility in BRCA+ people is impacted by
- ppx BSO
- baseline early onset menopause associated
- decreased ovarian reserve
- hx of chemo
therefore oocyte or embryo cyropreservation should be discussed